AzTrials
AzTrials

StressNCT07379606

Effects of Moderate Exercise and Cyclic Sighing on Stress, Cognition and Physiological Markers in Young Adults

A study testing Moderate-Intensity Physical Activity (PA) and Breathing Training - Cyclic Sighing (CS) in people with Stress, run by Poznan University of Physical Education at 1 site in Poland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study investigates the effects of moderate physical exercise and cyclic sighing (breathing training) on stress, cognition, and physiological markers in young adults. It is a randomized cross-over trial with two interventions. Each participant will take part in two intervention sessions: 1. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Stress
What is being tested?
Moderate-Intensity Physical Activity (PA) and Breathing Training - Cyclic Sighing (CS)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 sitePoland
Study dates
31 Jul 2026to 30 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • male or female participants,
  • age 18-35,
  • without chronic somatic diseases,
  • no current episode of psychiatric disorder (no active depression, mania, or psychosis),
  • regular sleep schedule in the week prior to the study,
  • not taking psychotropic drugs or medications,
  • non-smoker,
  • not working nightshifts.

Who cannot join

  • consumption of alcohol or psychoactive substances the day before or on the day of the study,
  • intense physical activity less than 2 hours before the study,
  • consuming coffee, black tee, energy drinks less than 2 hours before the study,
  • contraindications to moderate-intensity physical activity on cycle ergometer (e.g., recent injuries),
  • contraindications to EEG (e.g., scalp skin conditions preventing proper electrode placement, hypersensitivity to conductive gels or pastes).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Poland1 site, 1 recruiting
  • Poznan University of Physical Education

    Poznan, Wielkopolska, 61-871

    Szerment, (61) 835 51 12, szerment@awf.poznan.pl

    Recruiting

Other trials in Poland

About this study

Official title: A Comparison of Psychophysiological Effects Between Relaxation Techniques and Physical Exercise in Young Adults

This study investigates the effects of moderate physical exercise and cyclic sighing (breathing training) on stress, cognition, and physiological markers in young adults. It is a randomized cross-over trial with two interventions. Each participant will take part in two intervention sessions:

  1. Moderate-intensity physical activity (PA): 15 minutes of stationary cycling at 65-75% of maximum heart rate (HRmax).
  2. Breathing training (CS): 15 minutes of cyclic sighing, a technique involving inhaling, pausing briefly, taking a deeper breath, and exhaling slowly.
Read more

A one-week washout period between sessions is planned to minimise carry-over effects and to ensure participants' physiological state is similar before the next session. During this week, participants will wear Polar Ignite wrist-worn devices to monitor physical activity and sleep.

A total of 30 participants (you adults) will be enrolled.

Measurements performed before and after each intervention include:

  • EEG using Emotiv EPOC Flex Gel (32-channel device): 2 minutes with eyes open, 2 minutes with eyes closed, during the interventions, and while performing cognitive test (N-back).
  • Heart rate variability (HRV) using the Polar H10 sensor.
  • SUDS - Subjective Units of Disress Scale for perceived stress.
  • N-back test for cognitive performance using Emotiv App.
  • Blood pressure (systolic and diastolic) and heart rate.
  • Pain threshold measured with a dolorimeter.
  • PANAS-SF - Positive and Negative Affect Schedule.

Baseline questionnaires completed by participants the day before the study:

  • PSS-10 - Perceived Stress Scale (Cohen, Kamarck, Mermelstein).
  • MAAS - Mindful Attention Awareness Scale
  • Psychological well-being - short version
  • Mini-COPE - Coping with Stress Inventory
  • Sleep quality and average sleep duration
  • Chronotype questionnaire (morningness-eveningness)
  • GPAQ - Global Physical Activity Questionnaire
  • Pittsburgh Sleep Quality Index

The study aims to understand how brief interventions like moderate exercise and breathing techniques affect stress, cognitive performance, and physiological responses in young adults.

Conditions
Stress
Being tested
Moderate-Intensity Physical Activity (PA), Breathing Training - Cyclic Sighing (CS)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Moderate-Intensity Physical Activity (PA)Behavioural

    Participants perform 15 minutes of stationary cycling at moderate intensity.

  • Breathing Training - Cyclic Sighing (CS)Behavioural

    Participants perform 15 minutes of cyclic sighing (a breathing technique).

Study groups in NCT07379606
Study groupRoleWhat they receive
Moderate-Intensity Physical Activity (PA)ExperimentalParticipants perform 15 minutes of stationary cycling at moderate intensity.
Receives: Behavioral: Moderate-Intensity Physical Activity (PA)
Breathing Training - Cyclic Sighing (CS)ExperimentalParticipants perform 15 minutes of cyclic sighing.
Receives: Behavioral: Breathing Training - Cyclic Sighing (CS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean EEG spectral power in theta, alpha, low beta, high beta, gamma frequency bands during resting-state (eyes-open and eyes-closed)

    Mean spectral power in theta, alpha, low beta, high beta, and gamma frequency bands derived from resting-state EEG recordings collected during eyes-open and eyes-closed conditions. Spectral power will be calculated separately for eyes-open and eyes-closed resting-state conditions.

    Measured: Baseline: immediately before intervention; Post-intervention: immediately after completion of the intervention period

  2. Heart Rate Variability (HRV)

    HRV will be recorded at three time points. Baseline HRV will be calculated as the average over a 5-minute resting-state period immediately before intervention. HRV during the intervention will be calculated as the average over the entire intervention session (periprocedural). Post-intervention HRV will be calculated as the average over a 5-minute resting-state period immediately after intervention.

    Measured: Baseline (average over 5-minute resting-state immediately before intervention); During intervention (average over entire session, periprocedural); Post-intervention (average over 5-minute resting-state immediately after intervention).

Secondary outcomes (8)
  1. Mean EEG spectral power in theta, alpha, low beta, high beta, and gamma frequency bands during N-back task

    Mean spectral power in theta, alpha, low beta, high beta, and gamma frequency bands derived from EEG recordings collected during performance of the N-back cognitive task. Spectral power will be calculated separately for each frequency band and averaged across all EEG channels.

    Measured: Baseline (during N-back task immediately before each intervention session, periprocedural); Post-intervention (during N-back task immediately after each intervention session, periprocedural)

  2. Mean EEG spectral power in theta, alpha, low beta, high beta, and gamma frequency bands during intervention session

    Mean spectral power in theta, alpha, low beta, high beta, and gamma frequency bands derived from EEG recordings collected during the intervention session. Spectral power will be calculated separately for each frequency band and averaged across all EEG channels.

    Measured: During intervention session (periprocedural, averaged over entire session)

  3. Perceived Stress measured with the Subjective Units of Distress Scale (SUDS)

    Participants rate their perceived stress using the Subjective Units of Distress Scale (SUDS), a self-reported scale ranging from 0 (no stress) to 100 (extreme stress), where higher scores indicate higher perceived stress.

    Measured: Baseline: immediately before each intervention session; Post-intervention: immediately after each intervention session

  4. Cognitive Performance (N-back)

    Working memory assessed using N-back test with Emotiv app.

    Measured: Baseline: immediately before each intervention session; Post-intervention: immediately after each intervention session

  5. Blood Pressure

    Systolic and diastolic blood pressure measured using standard protocols.

    Measured: Baseline: immediately before each intervention session; Post-intervention: immediately after each intervention session

  6. Pain Threshold

    Pain threshold measured using a dolorimeter (algorimeter)

    Measured: Baseline: immediately before each intervention session; Post-intervention: immediately after each intervention session

  7. Positive and Negative Affect measured with the Positive and Negative Affect Schedule - Short Form (PANAS-SF)

    Participants complete the Positive and Negative Affect Schedule - Short Form (PANAS-SF), a self-reported scale assessing positive and negative affect. Each subscale contains 10 items rated from 1 (very slightly or not at all) to 5 (extremely), giving a possible score range of 10-50 for each subscale. Higher scores indicate higher levels of positive or negative affect, depending on the subscale.

    Measured: Baseline: immediately before each intervention session; Post-intervention: immediately after each intervention session

  8. Heart Rate

    Heart rate measured using standard protocols.

    Measured: Baseline: immediately before each intervention session; Post-intervention: immediately after each intervention session

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2026
  2. Study start31 Jul 2026
  3. Primary completion30 Apr 2027 (estimated)
  4. Study completion30 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07379606
Sponsor's protocol ID
716/25
Status last verified
Oct 2026
First submitted
19 Nov 2025
Last updated
2 Nov 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data (IPD) will be shared in the RepOD repository after study completion. An embargo of up to 36 months may apply to allow for publication of primary study results. Data will be available for scientific research purposes.

Questions about this trial

What is this clinical trial studying?

A study testing Moderate-Intensity Physical Activity (PA) and Breathing Training - Cyclic Sighing (CS) in people with Stress, run by Poznan University of Physical Education at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Beata Jóźwiak ((61) 835 53 49, b.jozwiak@awf.poznan.pl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean EEG spectral power in theta, alpha, low beta, high beta, gamma frequency bands during resting-state (eyes-open and eyes-closed) (time frame: Baseline: immediately before intervention; Post-intervention: immediately after completion of the intervention period). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in